World

Iran and the US agree on third round of nuclear discussions

Apr 20, 2025

Rome [Italy], April 20: Iran and the United States have agreed to further nuclear discussions after the second round of negotiations between them in Rome on Saturday.
Negotiations are set to continue on a technical level on Wednesday, and the diplomats plan to meet again in Oman next Saturday, Iranian Foreign Minister Abbas Araghchi was quoted by the Iranian news agency ISNA as saying.
The second round of talks in Rome was reportedly a four-hour session, and "the negotiations are progressing well," Araghchi said after the meeting with US Special Envoy Steve Witkoff. The US government has not commented on Saturday's second-round talks so far.
Representatives from Iran and the United States met at Oman's embassy in Rome on Saturday for the second round.
The Iranian negotiating delegation was led by Araghchi.
Ali Shamkhani, a political adviser to Supreme Leader Ali Khamenei, signalled Iran's willingness to reach an agreement in the nuclear dispute.
"We want a balanced agreement, not surrender," he wrote on X. Shamkhani called for a complete lifting of sanctions, including easing restrictions on foreign investment and an end to threats from Israel and the United States.
Source: Qatar Tribune

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025